Click on image to view larger version.

Figure 1 Percentage of Subjects With Clinical Diagnosis of FCH and With LDLR Mutation

Percentage of subjects with clinical diagnosis of familial combined hyperlipidemia (FCH) and with low-density lipoprotein receptor (LDLR) gene mutation. Columns represent the percentage in the whole group and in several subgroups. Subgroups have been defined according to the factors independently associated with the presence of LDLR mutation in the regression analysis. apoB = apolipoprotein B; APOE(–) = subjects without the APOE E2/E2 genotype or other rare APOE allele associated with hyperlipidemia; chol = cholesterol; DM(–) = subjects without diabetes mellitus.